International Stem Cell Corporation reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 0.131 million compared to USD 0.343 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.04 a year ago.
For the nine months, net income was USD 0.327 million compared to net loss of USD 0.354 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to basic loss per share from continuing operations of USD 0.04 a year ago.